New diabetes clinical trial: VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Published on: October 19, 2023 at 11:00PM
Conditions: Chronic Hepatitis B
Interventions: Drug: VIR-2218 and peginterferon alfa-2a
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/p2DNnU7